老年多病共存、多重用药与药物基因组学 - Suppr

Multimorbidity, polypharmacy and pharmacogenomics in old age.

作者信息

Brockmöller Jürgen, Stingl Julia C

机构信息

Institute of Clinical Pharmacology, Georg August University Göttingen, Robert-Koch-Str. 40 37075, Göttingen, Germany.

Research Division, Federal Institute for Drugs & Medical Devices, and Centre for Translational Medicine, University of Bonn, Kurt-Georg-Kiesinger-Allee 3 53175 Bonn, Germany.

出版信息

Pharmacogenomics. 2017 Apr;18(6):515-517. doi: 10.2217/pgs-2017-0026. Epub 2017 Mar 14.

DOI:10.2217/pgs-2017-0026

PMID:28290774

Abstract

摘要

相似文献

Multimorbidity, polypharmacy and pharmacogenomics in old age.

Pharmacogenomics. 2017 Apr;18(6):515-517. doi: 10.2217/pgs-2017-0026. Epub 2017 Mar 14.

Multimorbidity and polypharmacy among elderly people followed in general practices in Germany.

Eur J Intern Med. 2018 Sep;55:66-68. doi: 10.1016/j.ejim.2018.07.014. Epub 2018 Jul 17.

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review.

Pharmacogenomics J. 2022 Mar;22(2):89-99. doi: 10.1038/s41397-021-00260-6. Epub 2022 Feb 22.

Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).

Implement Sci. 2017 Apr 27;12(1):54. doi: 10.1186/s13012-017-0584-x.

[Drug therapy in the old age. Drug effects in the elderly].

MMW Fortschr Med. 2001 Dec 13;143(51-52):33-5.

Polypharmacy and specific comorbidities in university primary care settings.

Eur J Intern Med. 2016 Nov;35:35-42. doi: 10.1016/j.ejim.2016.05.022. Epub 2016 Jun 9.

Physical activity, muscular strength, and polypharmacy among older multimorbid persons: Results from the KORA-Age study.

Scand J Med Sci Sports. 2018 Feb;28(2):604-612. doi: 10.1111/sms.12884. Epub 2017 Apr 12.

Coexisting chronic conditions in the older population: Variation by health indicators.

Eur J Intern Med. 2016 Jun;31:29-34. doi: 10.1016/j.ejim.2016.02.014. Epub 2016 Mar 2.

Outcome prioritisation tool for medication review in older patients with multimorbidity: a pilot study in general practice.

Br J Gen Pract. 2017 Jul;67(660):e501-e506. doi: 10.3399/bjgp17X690485. Epub 2017 Mar 27.

[Not Available].

Drug Res (Stuttg). 2019 Nov;69(S 01):S9. doi: 10.1055/a-0982-5054. Epub 2019 Nov 15.

引用本文的文献

Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Cognitive Performance in Adults With Multiple Sclerosis.

Int J MS Care. 2024 Mar-Apr;26(2):81-88. doi: 10.7224/1537-2073.2023-014. Epub 2024 Mar 11.

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis.

J Clin Med. 2023 Aug 18;12(16):5379. doi: 10.3390/jcm12165379.

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review.

Pharmacogenomics J. 2022 Mar;22(2):89-99. doi: 10.1038/s41397-021-00260-6. Epub 2022 Feb 22.

Specific features of rational pharmacotherapy in elderly patients.

Eur J Hosp Pharm. 2023 Nov;30(6):322-327. doi: 10.1136/ejhpharm-2021-002980. Epub 2021 Nov 18.

Prevalence and Determinants of Multimorbidity, Polypharmacy, and Potentially Inappropriate Medication Use in the Older Outpatients: Findings from EuroAgeism H2020 ESR7 Project in Ethiopia.

Pharmaceuticals (Basel). 2021 Aug 25;14(9):844. doi: 10.3390/ph14090844.

An Update on Medication Use in Older Adults: a Narrative Review.

Curr Epidemiol Rep. 2021;8(3):108-115. doi: 10.1007/s40471-021-00274-5. Epub 2021 Jul 20.

Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.

Mo Med. 2021 May-Jun;118(3):239-245.

Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.

Croat Med J. 2020 Apr 30;61(2):147-158. doi: 10.3325/cmj.2020.61.147.

Evidence-based quality indicators for primary healthcare in association with the risk of hospitalisation: a population-based cohort study in Switzerland.

BMJ Open. 2020 Apr 23;10(4):e032700. doi: 10.1136/bmjopen-2019-032700.

Pharmacogenomic Approaches for Automated Medication Risk Assessment in People with Polypharmacy.

AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:142-151. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Multimorbidity, polypharmacy and pharmacogenomics in old age.

作者信息

Brockmöller Jürgen, Stingl Julia C

机构信息

Institute of Clinical Pharmacology, Georg August University Göttingen, Robert-Koch-Str. 40 37075, Göttingen, Germany.

Research Division, Federal Institute for Drugs & Medical Devices, and Centre for Translational Medicine, University of Bonn, Kurt-Georg-Kiesinger-Allee 3 53175 Bonn, Germany.

出版信息

Pharmacogenomics. 2017 Apr;18(6):515-517. doi: 10.2217/pgs-2017-0026. Epub 2017 Mar 14.

DOI:10.2217/pgs-2017-0026

PMID:28290774

Abstract

摘要

相似文献

Multimorbidity, polypharmacy and pharmacogenomics in old age.

Pharmacogenomics. 2017 Apr;18(6):515-517. doi: 10.2217/pgs-2017-0026. Epub 2017 Mar 14.

Multimorbidity and polypharmacy among elderly people followed in general practices in Germany.

Eur J Intern Med. 2018 Sep;55:66-68. doi: 10.1016/j.ejim.2018.07.014. Epub 2018 Jul 17.

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review.

Pharmacogenomics J. 2022 Mar;22(2):89-99. doi: 10.1038/s41397-021-00260-6. Epub 2022 Feb 22.

Implement Sci. 2017 Apr 27;12(1):54. doi: 10.1186/s13012-017-0584-x.

[Drug therapy in the old age. Drug effects in the elderly].

MMW Fortschr Med. 2001 Dec 13;143(51-52):33-5.

Polypharmacy and specific comorbidities in university primary care settings.

Eur J Intern Med. 2016 Nov;35:35-42. doi: 10.1016/j.ejim.2016.05.022. Epub 2016 Jun 9.

Physical activity, muscular strength, and polypharmacy among older multimorbid persons: Results from the KORA-Age study.

Scand J Med Sci Sports. 2018 Feb;28(2):604-612. doi: 10.1111/sms.12884. Epub 2017 Apr 12.

Coexisting chronic conditions in the older population: Variation by health indicators.

Eur J Intern Med. 2016 Jun;31:29-34. doi: 10.1016/j.ejim.2016.02.014. Epub 2016 Mar 2.

Outcome prioritisation tool for medication review in older patients with multimorbidity: a pilot study in general practice.

Br J Gen Pract. 2017 Jul;67(660):e501-e506. doi: 10.3399/bjgp17X690485. Epub 2017 Mar 27.

[Not Available].

Drug Res (Stuttg). 2019 Nov;69(S 01):S9. doi: 10.1055/a-0982-5054. Epub 2019 Nov 15.

引用本文的文献

Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Cognitive Performance in Adults With Multiple Sclerosis.

Int J MS Care. 2024 Mar-Apr;26(2):81-88. doi: 10.7224/1537-2073.2023-014. Epub 2024 Mar 11.

Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis.

J Clin Med. 2023 Aug 18;12(16):5379. doi: 10.3390/jcm12165379.

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review.

Pharmacogenomics J. 2022 Mar;22(2):89-99. doi: 10.1038/s41397-021-00260-6. Epub 2022 Feb 22.

Specific features of rational pharmacotherapy in elderly patients.

Eur J Hosp Pharm. 2023 Nov;30(6):322-327. doi: 10.1136/ejhpharm-2021-002980. Epub 2021 Nov 18.

Prevalence and Determinants of Multimorbidity, Polypharmacy, and Potentially Inappropriate Medication Use in the Older Outpatients: Findings from EuroAgeism H2020 ESR7 Project in Ethiopia.

Pharmaceuticals (Basel). 2021 Aug 25;14(9):844. doi: 10.3390/ph14090844.

An Update on Medication Use in Older Adults: a Narrative Review.

Curr Epidemiol Rep. 2021;8(3):108-115. doi: 10.1007/s40471-021-00274-5. Epub 2021 Jul 20.

Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.

Mo Med. 2021 May-Jun;118(3):239-245.

Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.

Croat Med J. 2020 Apr 30;61(2):147-158. doi: 10.3325/cmj.2020.61.147.

Evidence-based quality indicators for primary healthcare in association with the risk of hospitalisation: a population-based cohort study in Switzerland.

BMJ Open. 2020 Apr 23;10(4):e032700. doi: 10.1136/bmjopen-2019-032700.

Pharmacogenomic Approaches for Automated Medication Risk Assessment in People with Polypharmacy.

AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:142-151. eCollection 2018.

Multimorbidity, polypharmacy and pharmacogenomics in old age.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Multimorbidity, polypharmacy and pharmacogenomics in old age.

作者信息

机构信息

出版信息

相似文献

引用本文的文献